ARTICLE | Clinical News
Traumakine: Phase I/II data
February 10, 2014 8:00 AM UTC
Faron Pharmaceuticals Ltd., Turku, Finland Product: Traumakine ( FP-1201) Business: Pulmonary Molecular target: NA Description: Recombinant human interferon (IFN) beta-1a Indication: Treat acute resp...